FSDC To Keep Close Vigil On Illegal Influx Of Narcotics

Jaipur, 4 Jan 2024: The information of supplies made by Narcotic Drugs and Psychotropic Substances (NDPS) drug manufacturing companies established outside Rajasthan to the distributors of the state will be collected from drug controllers of the respective states.

If any difference is found in the quantity of supply, sale and stock, then action will be taken against all the parties concerned including the company. The stock of NDPS medicines should be limited on the lines of Uttar Pradesh and Uttarakhand.

The health department took the decision to ensure that the NDPS drugs should not be used for addiction, and it should only be used for the treatment of mental health issues.

The health department is taking necessary steps to save the young generation of the state from drug addiction and to realise the resolve of drug-free Rajasthan.

A health department official said in the meeting of the concerned departments on Tuesday, directions have been issued to strictly stop the illegal trade of narcotics and psychotropic drugs influx in the state.

The police and drug control department officials should ensure strict action against illegal sale of NDPS medicines. Effective monitoring of the sale of NDPS medicines should be done by licenced wholesale and retail drug dealers. If any seller is found selling such medicines without a licence, then action should be taken against him under the sections of NDPS Act, said a health department official.

If any licenced medicine seller is found involved in illegal NDPS drug trade, then a letter should be written to the Rajasthan Pharmacy Council to cancel the licence and registration of that shop and the pharmacist working at the shop. The social justice and empowerment department should take action against unregistered de-addiction centres.

Related Posts

  • Pharma
  • July 26, 2024
  • 116 views
US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

Maryland: The US Food and Drug Administration (FDA) has warned Brassica Pharma for numerous good manufacturing practice (GMP) violations, including multiple instances of employees falsifying sterility and environmental monitoring data and…

  • Pharma
  • July 26, 2024
  • 108 views
Indian National Charged With Selling Counterfeit Cancer Drugs

HOUSTON: A federal grand jury has returned an indictment charging an Indian national with selling and shipping tens of thousands of dollars in counterfeit oncology pharmaceuticals into the United States,…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

Indian National Charged With Selling Counterfeit Cancer Drugs

Indian National Charged With Selling Counterfeit Cancer Drugs

ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

BIS Sanctioned 82 Medical Device Projects To Develop Standards

BIS Sanctioned 82 Medical Device Projects To Develop Standards

Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM

Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM

‘Sunrise’ MedTech Industry in India & ‘Clouds’ strangling it, Brainstormed in PHD

‘Sunrise’ MedTech Industry in India & ‘Clouds’ strangling it, Brainstormed in PHD